3 completed, 1 active not recruiting, 1 unknown, 1 withdrawn. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 3, Active not recruiting 1, Unknown 1, Withdrawn 1 |
Follow Islets of Langerhans Transplantation: new trials by email Literature Review of Islets of Langerhans Transplantation trials Research Report on Islets of Langerhans Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes Islet graft, best medical care - Type 1 Diabetes | Phase 3 | Unknown | University Hospital, Grenoble | 42 | 2016-07-07 | 2022-06-24 |
| A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients Islet Cell Transplant - Type 1 Diabetes, Severe Hypoglycemic Unawareness | Phase 3 | Completed | Northwestern University | 10 | 2012-06-01 | 2026-06-18 |
| A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease islet cell transplant, Medical therapy - Diabetic Retinopathy, Diabetic Macular Edema | Phase 3 | Withdrawn | University of British Columbia | 2009-12-01 | 2014-03-17 | |
| Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol Islets of Langerhans transplantation - Type 1 Diabetes Mellitus | Phase 3 | Active not recruiting | CellTrans Inc. | 21 | 2007-09-05 | 2026-04-06 |
| Efficacy of Islet After Kidney Transplantation Islet transplantation, Antithymocyte Globulin, Daclizumab or Basiliximab - Type 1 Diabetes Mellitus | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 24 | 2007-01-01 | 2017-10-20 |
| Islet Transplantation in Type 1 Diabetes Allogeneic Pancreatic Islet Cells, Antithymocyte Globulin, Sirolimus - Type 1 Diabetes Mellitus | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 48 | 2006-10-01 | 2019-07-17 |
Diabetes Mellitus, Type 1 (6) · Hypoglycemia (3) · Diabetes Mellitus (1) · Diabetic Retinopathy (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · CellTrans Inc. (1) · Northwestern University (1) · University Hospital, Grenoble (1) · University of British Columbia (1)
United States (4) · Canada (2) · France (1) · Switzerland (1)
Ali Naji, PhD (1) · Andrew Posselt, MD, PhD (1) · Bernhard Hering, MD (1) · Camillo Ricordi, MD (1) · Daniel Borja-Cacho, MD (1) · David M. Thompson, MD (1) · James F. Markmann, MD, PhD (1) · James Shapiro, MD, PhD (1) · Jose Oberholzer, MD (1) · Nicole Turgeon, MD (1) · Olle Korsgren, PhD (1) · Xunrong Luo, MD, PhD (1)
PMID 23438305, PMID 23630300, PMID 25629445, PMID 27208344, PMID 27465220, PMID 28219959, PMID 29563196, PMID 29779835, PMID 39735417